South Africa: Concern Over HIV Drug Trial

A proposed trial of an old antiretroviral drug, stavudine, which is no longer recommended due to its side-effects, has raised concern among Aids activists who argue that its low cost is not enough reason to consider using it.

  • South Africa:  Stavudine Trial Causes Split

    Health-e, 11 June 2012

    AIDS activists and researchers are at loggerheads over the planned South African trial of a lower dose version of the controversial antiretroviral stavudine, which has in the past ... read more »

Receiving antiretroviral treatment.

  • Uganda:  New HIV/Aids Treatments (analysis)

    The Independent, 20 August 2011

    On Tuesdays, the Paediatric Ward at Mulago National Referral Hospital in Kampala is usually packed with young people from as early as 8am. Some stay glued to the big TV screen, ... read more »

  • Africa:  Bad News for Drug Prices in Middle-Income Countries

    PlusNews, 20 July 2011

    Middle-income countries with large numbers of people living with HIV will no longer benefit from preferential pricing when buying antiretroviral drugs from large pharmaceutical ... read more »

  • Kenya:  HIV Drugs 'That Cause Premature Aging' Named

    The Nation, 28 June 2011

    A class of HIV drugs common in Kenya has been found to cause premature aging and hasten heart and brain disorders. read more »

  • Zimbabwe:  Arvs - Side Effects Under Probe (analysis)

    The Herald, 10 February 2011

    THERE are some people who have been on ART for sometime now and had been doing well. read more »

Documents

InFocus